Company Cyber Security Posture
NANA
NA Company Details
NA
NA
NA
NA
NA
NA
Scan still pending
NA
NA
NA Risk Score (AI oriented)Between 200 and 800
This score is AI-generated and less favored by cyber insurers, who prefer the TPRM score.
NA Global Score.png)
Company Scoring based on AI Models
| Model Name | Date | Description | Current Score Difference | Score |
|---|---|---|---|---|
| AVERAGE-Industry | 03-12-2025 | This score represents the average cybersecurity rating of companies already scanned within the same industry. It provides a benchmark to compare an individual company's security posture against its industry peers. | N/A | Between 200 and 800 |
Company Cyber Security News & History
| Entity | Type | Severity | Impact | Seen | Url ID | Details | View |
|---|
Company Subsidiaries
NA
Access Data Using Our API
Get company history
Rapid.png)
NA Cyber Security News
Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report?
It has been about a month since the last earnings report for Krystal Biotech, Inc. (KRYS). Shares have lost about 3.5% in that time frame, ...
Implied Volatility Surging for Krystal Biotech Stock Options
Investors in Krystal Biotech, Inc. KRYS need to pay close attention to the stock based on moves in the options market lately.
Krystal Biotech's Q1 Earnings, Revenue Rise
Krystal Biotech, Inc. · Krystal Biotech's Q1 Earnings, Revenue Rise. Published on 05/06/2025 at 08:27. LinkedIn X (ex-Twitter) WhatsApp Telegram Copy.
Why This Biotech, With A 65% Gain, Could Keep Sprinting
Krystal Biotech stock has a strong Composite Rating of 93 out of a best-possible 99. This means shares rank in the leading 7% of all stocks when ...
Krystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...
Krystal Biotech Inc (KRYS) reports a 95% increase in net revenue and prepares for a major European launch amid strong financial positioning.
U.S. FDA approves Krystal Biotech's skin-disorder gene therapy
The U.S. Food and Drug Administration on Friday approved Krystal Biotech Inc's first-of-its kind topical gene therapy for patients with a ...
Krystal Biotech Q4 Earnings Beat Estimates, Sales Miss, Stock Up
Krystal Biotech KRYS reported fourth-quarter earnings per share of $1.52, which beat the Zacks Consensus Estimate of $1.29 as Vyjuvek gains ...
US FDA approves Krystal Biotech’s Vyjuvek for DEB
The US FDA has granted approval for Krystal Biotech's Vyjuvek to treat dystrophic epidermolysis bullosa (DEB).
Krystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term Gain
We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take a look at ...
NA Similar Companies
Regeneron
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, ma
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
NA CyberSecurity History Information
How many cyber incidents has NA faced?
Total Incidents: According to Rankiteo, NA has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at NA?
Incident Types: The types of cybersecurity incidents that have occurred include .
Additional Questions
What Do We Measure?
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
